#ai-in-drug-discovery

[ follow ]
from24/7 Wall St.
1 day ago

2 Brilliant Biotech ETFs to Watch in 2026

As the AI trade gets overheated and calls for some sort of bursting of the AI bubble grow louder, it might make sense to look to opportunities to be had within other sectors. Undoubtedly, the AI-fuelled tech boom may very well continue for another year or more, as the firms strive to be among the first to achieve some form of artificial general intelligence (AGI). Still, there's no denying that the stakes are higher, along with valuations.
Business
fromFast Company
3 months ago

Bet on the big idea-the only way to change the world

But at the time, his skepticism represented a familiar story: Bold, visionary ideas are met with resistance and fear from industries entrenched in conventional wisdom. Yet, time and again, we've seen how disruptors use technology and sheer conviction to rewrite the rules and yield transformative outcomes. In the last decade alone, this played out across industries like transportation, aerospace, and defense-from electric vehicles challenging Detroit to reusable rockets shattering the assumption of expendable space travel.
Medicine
Photography
fromFast Company
4 months ago

Eli Lilly signs $1.3 billion deal with Superluminal to use AI to make obesity medicines

Eli Lilly has signed a $1.3 billion deal with Superluminal Medicines to develop AI-driven drugs targeting obesity and cardiometabolic diseases.
[ Load more ]